medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	A mixed methods study of multidisciplinary team assessment and therapeutic decision making for intestinal strictures in Crohn's disease. Sci Rep He X, Sun X, Zhang G, Li W, Bai X, Ruan G, Sun Y, Xu H, Lv H, Shu H, Li Y, Tan B, Li J, Qin J, Wang L, Zhu Q, Cong L, Yang H, Qian J. PMID: 41781595 [PubMed - as supplied by publisher]
	Serum biomarkers for predicting Crohn's disease activity: The role of bilirubin, uric acid, and the C-reactive protein/albumin ratio. PLoS One Xu T, Yao T, Chen Y, Xu F, Lu C. PMID: 41779698 [PubMed - in process]
	Risk of intestinal cancer in Crohn's disease: re-analysis and meta-regression of population-based cohort studies. J Crohns Colitis Giusto EA, Pinton P, Giorgi C, Serino G, Giannelli G, Donghia R, Fiorica F. PMID: 41778611 [PubMed - in process]
	Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study. Inflamm Bowel Dis Sands BE, Clemow DB, D'Haens G, Irving PM, Kobayashi T, Peyrin-Biroulet L, Samaan K, Gaur A, Arora R, Todd K, Moses R, Dignass A. PMID: 41777218 [PubMed - as supplied by publisher]
	Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with ulcerative colitis: a post hoc analysis of the SELECTION and SELECTION long-term extension trials. Intest Res Matsuoka K, Schreiber S, Hata E, Kaise T, Hibi T. PMID: 41777058 [PubMed - as supplied by publisher]
	Phthalates exposure and serum uric acid level in patients with Crohn's disease: A cross-sectional study. PLoS One Liu X, Qingzhuoga D, Xiong D, Wang L, Hou X, Tao B, Yang L, Zhu L, Tu L. PMID: 41774723 [PubMed - in process]
	Identification of Novel Biomarkers for Crohn's Disease Through the Integration of Machine Learning, Colocalization, and SMR Analysis. FASEB J Chen L, Hua J. PMID: 41773807 [PubMed - in process]
	Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease. Aliment Pharmacol Ther Wang R, Wu Y, Xu D, Yang Y, Qian K, Kuang J, Wang X, Lin C, Liu X, Wu G, Ruan D, Chen B, Zhang Y, Li Y, Wang Z, Cui Z, Cao D. PMID: 41773382 [PubMed - as supplied by publisher]
	Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review. Inflammopharmacology Bahaa MM, Abdallah MS, Mosalam EM, Gardouh AR, Nazih M, Hamza E, Al-Dhelaan RA, Kamal N. PMID: 41770503 [PubMed - as supplied by publisher]
	Effect of 5-Aminosalicylate Dose Reduction or Withdrawal on Prognosis in Patients with Ulcerative Colitis Receiving Advanced Therapy: A Multicenter Retrospective Cohort Study. Dig Dis Sci Sano Y, Yagi N, Ito Y, Nakamura N, Honzawa Y, Saito E, Fukata N, Okazaki K, Shimatani M, Naganuma M. PMID: 41770422 [PubMed - as supplied by publisher]
	TUG1 and H19 lncRNAs Can Predict Anti-TNF Unresponsiveness in Patients With Ulcerative Colitis: A Machine Learning-Based Approach. Mediators Inflamm Heydari R, Tavassolifar MJ, Nazari MHD, Roshannia R, Shahrokh S, Parvizi M, Norooz MT, Meyfour A. PMID: 41769045 [PubMed - in process]
	Effectiveness of Intravenous Corticosteroid in Patients with Ulcerative Colitis after Oral Corticosteroid Failure: Differences by Prior Response to Oral Therapy in a Multicenter Cohort Study. Inflamm Intest Dis Fukuda T, Tatsumi K, Inagaki N, Ikeda A, Ogata N, Kanazawa J, Nakamori Y, Endo T, Kuroki H, Kuroki Y, Ueda T, Yoshida A, Kanagawa IBD Study Group. PMID: 41766926 [PubMed]
	Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study. J Pediatr Gastroenterol Nutr Steiner SJ, Adler J, Saeed SA, Strauss RS, Howe KM, Sheahan A, Zhang R, Keihn KR, Harrow K, Olano KK, Evans DA, Lo KH, Zhang N, Kim L, Colletti RB, Volger S, ImproveCareNow Learning Health Network. PMID: 41766590 [PubMed - as supplied by publisher]
	Refining endoscopic diagnosis in ulcerative colitis: the emerging role of lesion-border distinctness combined with pit pattern analysis. Gastrointest Endosc Saito Y. PMID: 41763860 [PubMed - in process]
	EARLY INTERVENTION PREVENTS DISEASE PROGRESSION IN ULCERATIVE COLITIS - A MULTICENTER RETROSPECTIVE STUDY. Clin Gastroenterol Hepatol Neves JC, Leal T, Fernandes S, Sousa DC, Neves AS, Cristiano M, Portela F, Costa C, Ferreira R, Portugal M, Oliveira R, Gututui M, Bastos A, Santos PB, Silva AR, Gomes P, Damasceno J, Guimarães A, Conde PV, Mendes S, Soares J, Arroja B, Gonçalves R, Costa D. PMID: 41763461 [PubMed - as supplied by publisher]
	Dietary Interventions With Solid Foods in Adults With Crohn Disease: Methodological Insights From a Scoping Review. Nutr Rev Morogianni K, Karayiannis D, Almperti A, Karatzi K, Manolakis A, Viazis N, Archavlis E, Mantzaris GJ, Poulia KA. PMID: 41762698 [PubMed - as supplied by publisher]
	Machine learning framework for early identification of high-spending Crohn's disease patients using administrative claims. BMJ Health Care Inform Wylezinski LS, Gray JD, Spurlock CF 3rd. PMID: 41760348 [PubMed - in process]
	Fc-gamma receptors type3A (rs396991) genotyping for predicting infliximab efficacy and immunogenicity in ulcerative colitis: An observational study of Iraqi cohort. Medicine (Baltimore) Al-Jalehawi AK, Mohammed SI. PMID: 41759997 [PubMed - in process]
	Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn's disease risk. medRxiv Wang S, Dan L, Ruan X, Wellens J, Sun Y, Yao J, Tian L, Kalla R, Theodoratou E, Yuan S, Larsson SC, Ludvigsson JF, Peyrin-Biroulet L, Satsangi J, Magro F, Li X, Wang X, Chen J. PMID: 41757175 [PubMed]
	Association between the C-reactive protein to albumin ratio and unplanned readmission in ulcerative colitis: insights from a cohort study. Front Med (Lausanne) Zhan J, Wang T, Zhao X, Zhu J, Ji S, Zhao Y, Wang D. PMID: 41756374 [PubMed]

Artikel 1 - 20 / 56882

Seite 1 von 2845



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung